MicroPort Endovascular adjusts 2025 semi-annual cash dividend after share repurchases

Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. has announced an adjustment to its 2025 semi-annual profit distribution, with the total cash dividend decreasing from 157,408,999.80 yuan to 157,185,566.20 yuan (tax inclusive). The per-share dividend remains unchanged at 13 yuan per 10 shares (tax inclusive), reflecting the company's commitment to maintaining its per-share distribution ratio.

This adjustment stems from the company's share repurchase program. Between August 1, 2025, and the announcement date, MicroPort Endovascular repurchased 171,872 shares through the Shanghai Stock Exchange. As a result, the total number of shares participating in the dividend distribution has been adjusted to 120,911,974 shares.

Previously, the company's total share capital as of July 31, 2025, was 123,262,117 shares, with 2,178,271 shares held in the buyback special securities account. The original calculation for the dividend total was based on 121,083,846 shares. With the latest repurchases, the number of shares in the buyback account has increased to 2,350,143 shares, leading to the revised total dividend. The distribution will not include bonus shares or capitalization from the capital reserve.